Short-term Effect of Verapamil on Coronary No-Reflow Associated With Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Author:
Affiliation:
1. Department of Cardiology; The First Affiliated Hospital of Guangxi Medical University, Guangxi Cardiovascular Institute; Nanning; China
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22143/fullpdf
Reference21 articles.
1. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction;Dong-bao;Clin Cardiol.,2010
2. No-reflow phenomenon during percutaneous coronary intervention;Chen;Adv Cardiovasc Dis.,2005
3. Pharmacological management of no-reflow during percutaneous coronary intervention;Porto;Curr Vasc Pharmacol.,2006
4. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction;Werner;Catheter Cardiovasc Interv.,2002
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mixture of Doxycycline, ML-7 and L-NAME Restores the Pro- and Antioxidant Balance during Myocardial Infarction—In Vivo Pig Model Study;Biomedicines;2024-04-02
2. Sugarcane leaf polysaccharide exerts a therapeutic effect on cardiovascular diseases through necroptosis;Heliyon;2023-11
3. No-reflow phenomenon in STEMI: beyond a good angiographic result;Revista Española de Cardiología (English Edition);2022-09
4. Fenómeno de no-reflow en el IAMCEST: más allá de un buen resultado angiográfico;Revista Española de Cardiología;2022-09
5. Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome;The International Journal of Cardiovascular Imaging;2022-02-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3